Skip to main content
Fig. 1 | BMC Psychiatry

Fig. 1

From: Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

Fig. 1

Clinical study flow diagram. Number of patients is given with dropout numbers in brackets. M-6 (risperidone LAI initiation, 6 months before inclusion), M0 (month 0, first evaluation visit), M3 (month 3, follow-up visit), M6 (month 6, end of study)

Back to article page